These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22548259)

  • 1. Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma: comments on the article by Danielides et al.
    Park SJ; Shin JI
    Scand J Rheumatol; 2012 May; 41(3):248. PubMed ID: 22548259
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma.
    Danielides S; Mavragani CP; Katsakoulas I; Zintzaras E; Drosos AA; Vlachoyiannopoulos PG; Moutsopoulos HM
    Scand J Rheumatol; 2011; 40(4):299-303. PubMed ID: 21417550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired haemophilia A in a patient with limited cutaneous systemic sclerosis.
    Glas HK; Kwok WY; Ypma PF; Goekoop RJ
    Rheumatology (Oxford); 2021 Oct; 60(10):e360-e361. PubMed ID: 33878170
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleroderma and liver disease: a case of an association with primary sclerosing cholangitis.
    Zampetti A; Rinninella E; Manna R; Franceschi F
    Scand J Rheumatol; 2016 Jul; 45(4):334-5. PubMed ID: 26690847
    [No Abstract]   [Full Text] [Related]  

  • 5. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
    Graf SW; Hakendorf P; Lester S; Patterson K; Walker JG; Smith MD; Ahern MJ; Roberts-Thomson PJ
    Int J Rheum Dis; 2012 Feb; 15(1):102-9. PubMed ID: 22324953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study to determine whether transient receptor potential melastatin type 8 (TRPM8) antibodies are detected in scleroderma.
    Shah AA; Montagne J; Oh SY; Wigley FM; Casciola-Rosen L
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S123-6. PubMed ID: 26242276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury.
    Assous N; Allanore Y; Batteux F; Meune C; Toulon P; Weill B; Kahan A
    Clin Exp Rheumatol; 2005; 23(2):199-204. PubMed ID: 15895890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B).
    Servettaz A; Tamby MC; Guilpain P; Reinbolt J; Garcia de la Penã-Lefebvre P; Allanore Y; Kahan A; Meyer O; Guillevin L; Mouthon L
    Clin Immunol; 2006 Aug; 120(2):212-9. PubMed ID: 16580263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical profiles of 'autoantibody-negative' systemic sclerosis subjects.
    Hudson M; Satoh M; Chan JY; Tatibouet S; Mehra S; Baron M; Fritzler M;
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-127-32. PubMed ID: 24144389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
    Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
    Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA markers for susceptibility and expression in scleroderma.
    Gladman DD; Kung TN; Siannis F; Pellett F; Farewell VT; Lee P
    J Rheumatol; 2005 Aug; 32(8):1481-7. PubMed ID: 16078323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis in Argentina: evaluation of a large cohort from a single centre and comparison with other international series.
    Scolnik M; Lancioni E; Saucedo C; Marin J; Sabelli M; Bedran Z; Soriano ER; Catoggio LJ
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-94-7. PubMed ID: 25198424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of systemic sclerosis.
    Nikpour M; Stevens WM; Herrick AL; Proudman SM
    Best Pract Res Clin Rheumatol; 2010 Dec; 24(6):857-69. PubMed ID: 21665131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of Cushing's syndrome and exacerbation of autoimmune thyroiditis.
    Niepomniszcze H; Pitoia F
    Thyroid; 2011 Feb; 21(2):207; author reply 208. PubMed ID: 21275768
    [No Abstract]   [Full Text] [Related]  

  • 19. Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.
    Alexandrescu DT; Popoveniuc G; Farzanmehr H; Dasanu CA; Dawson N; Wartofsky L
    Thyroid; 2008 Jul; 18(7):809-12. PubMed ID: 18631016
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis.
    van Bon L; Popa C; Huijbens R; Vonk M; York M; Simms R; Hesselstrand R; Wuttge DM; Lafyatis R; Radstake TR
    Ann Rheum Dis; 2010 Aug; 69(8):1539-47. PubMed ID: 20498209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.